Mechanisms Mediating the Effects of<i>γ</i>-Tocotrienol When Used in Combination with PPAR<i>γ</i>Agonists or Antagonists on MCF-7 and MDA-MB-231 Breast Cancer Cells
Abhita Malaviya(University of Louisiana at Monroe), Paul W. Sylvester(University of Louisiana at Monroe)
Cited by 21
Related Papers
γ‐Tocotrienol inhibits ErbB3‐dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells
|Cell Proliferation|2006|112
Enhanced antiproliferative and apoptotic response to combined treatment of γ-tocotrienol with erlotinib or gefitinib in mammary tumor cells
|BMC Cancer|2010|57
γ‐Tocotrienol reversal of epithelial‐to‐mesenchymal transition in human breast cancer cells is associated with inhibition of canonical Wnt signalling
|Cell Proliferation|2016|40
Anti‐proliferative effects of γ‐tocotrienol are associated with suppression of c‐Myc expression in mammary tumour cells
|Cell Proliferation|2015|31
Anticancer Effects of γ-Tocotrienol Are Associated with a Suppression in Aerobic Glycolysis
|Biological and Pharmaceutical Bulletin|2015|22